Sign Out
Hypersensitivity to the active substance, soya, peanut or to any of the excipients.
Severe liver impairment.
Active pathological bleeding such as peptic ulcer or intracranial haemorrhage.
The concomitant use of this product and repaglinide is contraindicated.
